J&J pulls the plug on 340B re­bate mod­el changes op­posed by gov­ern­ment

John­son & John­son has called off plans to im­ple­ment a new re­bate mod­el for 340B drug price dis­counts fol­low­ing threats from the fed­er­al gov­ern­ment. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA